1.
Vít Procházka, Antonín Hluší. Ibritumomab tiuxetan plus BEAM in refractory diffuse large B-cell lymphoma. Haematologica 2014;99(7):e108-e108; https://doi.org/10.3324/haematol.2014.107177.